AT
Alveus Therapeutics, Inc.
SEC filingPharmaceuticals · Philadelphia, PA
Amount raised$56.9Msold at filing
Total offering$110.7M$53.9M still open
Investors in the raise17count reported to the SEC
FiledJan 14, 2026first sale Dec 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Claudio NessiDirector
Ameet NathwaniDirector
Ivan GergelDirector
Jan Van de BosscheDirector
Carlo de NotaristefaniDirector
Garrett IngramDirector
Raj KannanExecutive Officer, Director
Gregory ParekhDirector
Executive officers, directors and promoters as listed on the Form D.